[Apr 30 – May 2] Kootenay Tour

[Apr 30 – May 2] Kootenay Tour

Therapeutics Initiative dine & learn Kootenay Tour

10 topics, 5 faculty, accredited for up to 3.5 Mainpro+

Registration deadline: April 25

CRANBROOK

NELSON

ROSSLAND

AGENDA:

17:30 Dinner

17:45 Recognizing subtle manifestations of drug toxicity

18:00 Deprescribing antidepressants

18:15 How to stop PPIs (the low-hanging rotten fruit)

18:35 Practical Deprescribing

19:20 Panel – All TI Faculty

19:35 Break & Dessert

19:50 Breakout 1

  • Update on the evidence for COPD inhalers (Triple therapy, LAMA, LABA, ICS/LABA)
  • What is the evidence for domperidone for breastfeeding mothers?

20:20 Breakout 2

  • Cyclobenzaprine for pain (setting realistic expectations)
  • Does using CV risk calculators help our patients?

20:50 Breakout 3

  • Vitamin D: what is it good for?
  • Shedding light on the risks of anticholinergic drugs

FACULTY:

  • Dr. Aaron Tejani, BSc (Pharm), PharmD. Researcher and educator, Drug Assessment Working Group and Education Working Group, Therapeutics Initiative
  • Dr. Cait O’Sullivan, BA, BScPh, PharmD. Clinical Pharmacist, Continuing Medical Education, Island Health Clinical Pharmacy Programs, BC Provincial Academic Detailing (PAD) Service
  • Lori Verigin, NP. Adjunct Faculty at University of Victoria, Instructor with Thompson Rivers University
  • Dr. Lorri Puil, MD, PhD. Editor, Cochrane Hypertension, Dept. of Anesthesiology, Pharmacology & Therapeutics University of British Columbia
  • Dr. Thomas Perry Jr., MD, FRCP. Clinical Associate Professor, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, UBC, Specialist physician in General Internal Medicine and Clinical Pharmacology, Chair, Education Working Group, Therapeutics Initiative

This is a collaboration between the UBC Therapeutics Initiative and the Kootenay Boundary Division of Family Practice (a GPSC initiative).

No Comments

Post A Comment